11.41
price down icon0.61%   -0.07
pre-market  Pre-mercato:  11.47   0.06   +0.53%
loading
Precedente Chiudi:
$11.48
Aprire:
$11.39
Volume 24 ore:
3.13M
Relative Volume:
0.68
Capitalizzazione di mercato:
$5.64B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
28.52
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-0.87%
1M Prestazione:
-0.17%
6M Prestazione:
-12.50%
1 anno Prestazione:
-28.55%
Intervallo 1D:
Value
$11.31
$11.57
Intervallo di 1 settimana:
Value
$11.31
$12.17
Portata 52W:
Value
$11.11
$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Nome
Elanco Animal Health Inc
Name
Telefono
877-352-6261
Name
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Name
Dipendente
9,800
Name
Cinguettio
@Elanco
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ELAN's Discussions on Twitter

Confronta ELAN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
11.41 5.64B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
174.29 78.63B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.85 44.54B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 42.61B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.59 18.79B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
127.56 13.55B 612.78M -86.37M -62.91M -0.87

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-09 Iniziato UBS Buy
2024-12-02 Iniziato Leerink Partners Market Perform
2024-09-19 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-01-05 Aggiornamento Stifel Hold → Buy
2023-12-19 Iniziato Jefferies Buy
2023-12-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-12-07 Iniziato Exane BNP Paribas Outperform
2023-04-20 Aggiornamento Barclays Equal Weight → Overweight
2022-08-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-08-16 Downgrade JP Morgan Overweight → Neutral
2022-07-21 Downgrade Goldman Buy → Sell
2022-07-12 Iniziato Piper Sandler Neutral
2021-11-18 Iniziato Morgan Stanley Overweight
2021-10-28 Downgrade Stifel Buy → Hold
2021-08-05 Ripresa Credit Suisse Outperform
2021-06-15 Aggiornamento Cleveland Research Underperform → Neutral
2021-05-11 Aggiornamento Barclays Underweight → Equal Weight
2021-05-11 Aggiornamento Gabelli & Co Hold → Buy
2021-04-15 Iniziato Stifel Buy
2021-03-22 Downgrade Gabelli & Co Buy → Hold
2021-02-26 Aggiornamento Credit Suisse Neutral → Outperform
2020-12-09 Downgrade Argus Buy → Hold
2020-11-09 Downgrade Barclays Overweight → Underweight
2020-08-20 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-08-13 Ripresa Credit Suisse Neutral
2020-08-04 Ripresa Goldman Buy
2020-07-27 Downgrade Cleveland Research Neutral → Underperform
2020-04-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-10 Iniziato Raymond James Mkt Perform
2019-12-19 Aggiornamento BofA/Merrill Neutral → Buy
2019-11-07 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-09-23 Iniziato Barclays Overweight
2019-08-26 Downgrade BofA/Merrill Buy → Neutral
2019-08-15 Aggiornamento UBS Sell → Neutral
2019-05-23 Iniziato Guggenheim Neutral
2019-03-18 Aggiornamento BofA/Merrill Neutral → Buy
2019-03-13 Ripresa Morgan Stanley Equal-Weight
2019-02-12 Iniziato William Blair Mkt Perform
2019-01-23 Iniziato UBS Sell
2019-01-15 Iniziato Argus Buy
2018-10-15 Iniziato Morgan Stanley Equal-Weight
Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

pulisher
Feb 11, 2025

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider

Feb 11, 2025
pulisher
Feb 11, 2025

125,807 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Purchased by Equitable Trust Co. - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Veterinary Medicine Market Growth, Demand, Industry Size & - openPR

Feb 11, 2025
pulisher
Feb 10, 2025

(ELAN)Analyzing Elanco Animal Health's Short Interest - Benzinga

Feb 10, 2025
pulisher
Feb 10, 2025

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Feb 10, 2025
pulisher
Feb 10, 2025

Veterinary Infectious Diseases Therapeutics Market Share - openPR

Feb 10, 2025
pulisher
Feb 10, 2025

Private Management Group Inc. Grows Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Feb 10, 2025
pulisher
Feb 09, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider

Feb 09, 2025
pulisher
Feb 08, 2025

Animal Doctor: Concerns about several veterinary drug products - Washington Times Herald

Feb 08, 2025
pulisher
Feb 08, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Caprock Group LLC - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

Veterinary Eye Care Market to Grow by USD 1.05 Billion(2024-2028), Boosted by Rising Pet Ownership & Market Transformation Driven by AITechnavio - The Malaysian Reserve

Feb 07, 2025
pulisher
Feb 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Markets Insider

Feb 06, 2025
pulisher
Feb 06, 2025

Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

India’s Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

Animal Parasiticides Market Witness Growth: Size, Share, - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Elanco Launches Pradalex for Treatment of Livestock Respiratory Diseases - Drovers Magazine

Feb 05, 2025
pulisher
Feb 05, 2025

BlackRock, Inc.'s Strategic Acquisition of Elanco Animal Health Inc Shares - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Elanco launches novel treatment for livestock respiratory diseases - Feedstuffs

Feb 05, 2025
pulisher
Feb 05, 2025

Pet Pharmaceuticals Market Growth to Accelerate in Forecast - openPR

Feb 05, 2025
pulisher
Feb 04, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by KBC Group NV - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out - yourbigsky.com

Feb 04, 2025
pulisher
Feb 04, 2025

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - Markets Insider

Feb 03, 2025
pulisher
Feb 03, 2025

Jim Cramer on Elanco Animal Health Incorporated (ELAN): ‘Not My Favorite’ - Insider Monkey

Feb 03, 2025
pulisher
Feb 02, 2025

Elanco Animal Health (NYSE:ELAN) Given New $14.00 Price Target at Morgan Stanley - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Feb 01, 2025
pulisher
Jan 30, 2025

Meet the Faces of Zen: Elanco’s Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - 3BL Media

Jan 30, 2025
pulisher
Jan 30, 2025

Elanco Animal demitasse Health Incorporated - The Branding Iron

Jan 30, 2025
pulisher
Jan 30, 2025

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL

Jan 30, 2025
pulisher
Jan 30, 2025

Veterinary Medicine Market Is Booming Worldwide 2025-2032 | - openPR

Jan 30, 2025
pulisher
Jan 30, 2025

Meet the Faces of Zen: Elanco's Zenrelia(TM) (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - Yahoo Finance

Jan 30, 2025
pulisher
Jan 29, 2025

Elanco price target lowered to $14 from $15 at Morgan Stanley - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

2025-01-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 29, 2025
pulisher
Jan 28, 2025

ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Elanco Animal Health Incorporated and Urges Investors to Contact the Firm Today! - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 28, 2025

Investors Who Lost Money With Elanco Animal Health Incorporated (NYSE:ELAN) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - accessnewswire.com

Jan 28, 2025
pulisher
Jan 27, 2025

Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - PR Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

ELAN FRAUD NOTICE: Lose Money on Your Elanco Investment? BFA Law is Investigating the Company for Securities Fraud and Urges You to Contact the Firm (NYSE:ELAN) - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 26, 2025

2025-01-26 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 26, 2025
pulisher
Jan 25, 2025

ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 25, 2025

Elanco Animal Health (ELAN) Faces Investor Suit Over Zenrelia Safety ConcernsHagens Berman - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

Senior, geriatric dog care focus of new industry partnership - VeterinaryPracticeNews.com

Jan 24, 2025
pulisher
Jan 24, 2025

Animal Gastroesophageal Reflux Disease Market Analysis Report 2025-2030, with Profiles of Key Players Zoetis, Merck, Elanco, Ceva, BioZyme, Annamaet Petfoods, Hill's Pet Nutrition, Blue Buffalo & More - Yahoo Finance

Jan 24, 2025
pulisher
Jan 23, 2025

Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind - PR Newswire

Jan 23, 2025
pulisher
Jan 23, 2025

Assenagon Asset Management S.A. Sells 1,369,833 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

2025-01-22 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 22, 2025
pulisher
Jan 22, 2025

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Benzinga

Jan 22, 2025
pulisher
Jan 21, 2025

UK Veterinary Medicine Market May See a Big Move | Norbrook, Merck, Elanco - openPR

Jan 21, 2025
pulisher
Jan 21, 2025

Is Elanco Animal Health Incorporated (ELAN) the Most Undervalued Stock to Invest in for Under $20? - Insider Monkey

Jan 21, 2025
pulisher
Jan 20, 2025

12 Most Undervalued Stocks to Invest in for Under $20 - Insider Monkey

Jan 20, 2025
pulisher
Jan 20, 2025

Top animal health companies by revenue worldwide 2023 - Statista

Jan 20, 2025
pulisher
Jan 19, 2025

2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 19, 2025

Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$81.92
price down icon 5.74%
$31.96
price up icon 2.34%
$116.85
price down icon 1.65%
$10.61
price down icon 0.09%
$127.56
price up icon 0.35%
Capitalizzazione:     |  Volume (24 ore):